|
Status |
Public on Jul 29, 2020 |
Title |
CAFInhib1 |
Sample type |
SRA |
|
|
Source name |
KPC cell line
|
Organism |
Mus musculus |
Characteristics |
treatment: miR-224 inhibitor replicate: 1 cell type: CAF
|
Treatment protocol |
miRNA lentiviral particles were purchased from GeneCopoeia with third generation technology for stable transduction
|
Growth protocol |
Tumor cells, KPC CAFs, and PNAFs were maintained in RPMI 1640 with 10% FBS, 1 mM sodium pyruvate, 2 mM L-glutamine, 1% nonessential amino acids, penicillin (50 U/ml)/streptomycin (50 g/ml) (Life Technologies), and 0.2 U/ml human insulin (NovoLog) in a humidified incubator (37 degrees, 5% CO2)
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA extraction following stable transduction with RNAqueous micro kit Illumina’s TruSeq Stranded Total RNA Sample Prep Kit
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Description |
CAFScr_vs_CAFInhib_all_isoforms_sorted.txt
|
Data processing |
Illumina's CASAVA 1.8.4 was used to convert BCL files to FASTQ files rsem-1.3.0 was used for running the alignments as well as generating gene and transcript expression levels. rsem-1.3.0's EBSeq was used for Differential Expression analysis Genome_build: RSEM version 1.3.0, aligned to reference genome mm10
|
|
|
Submission date |
Jan 08, 2020 |
Last update date |
Jul 29, 2020 |
Contact name |
Jacquelyn W Zimmerman |
E-mail(s) |
[email protected], [email protected]
|
Phone |
2566824782
|
Organization name |
Johns Hopkins Sidney Kimmel Comp. Cancer Center
|
Street address |
1650 Orleans St, Room 186
|
City |
Baltimore |
State/province |
Maryland |
ZIP/Postal code |
21287 |
Country |
USA |
|
|
Platform ID |
GPL17021 |
Series (1) |
GSE143326 |
Inhibition of miR-21 regulates mutant KRAS effector pathways and intercepts pancreatic ductal adenocarcinoma development |
|
Relations |
BioSample |
SAMN13795912 |
SRA |
SRX7527433 |